Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.35% | -2.29% | -5.14% | -19.86% | -42.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.35% | -2.29% | -5.14% | -19.86% | -42.39% |
| Cost of Revenue | -14.94% | -9.48% | -19.25% | -23.14% | -40.31% |
| Gross Profit | -9.15% | 2.21% | 4.30% | -17.91% | -43.59% |
| SG&A Expenses | -11.52% | -5.83% | -14.26% | -21.02% | -25.72% |
| Depreciation & Amortization | -34.18% | -10.20% | 14.05% | -1.25% | -1.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.56% | -7.11% | -12.96% | -19.93% | -28.01% |
| Operating Income | 19.57% | 14.30% | 25.19% | 20.01% | -18.13% |
| Income Before Tax | 16.91% | 6.12% | 17.89% | 17.39% | -23.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 16.91% | 6.12% | 17.89% | 17.39% | -23.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 16.91% | 6.12% | 17.89% | 17.39% | -23.62% |
| EBIT | 19.57% | 14.30% | 25.19% | 20.01% | -18.13% |
| EBITDA | 13.96% | 15.04% | 35.47% | 24.64% | -25.33% |
| EPS Basic | 17.31% | 7.55% | 18.97% | 16.95% | -23.81% |
| Normalized Basic EPS | 18.18% | 6.06% | 16.67% | 16.22% | -22.22% |
| EPS Diluted | 17.31% | 7.55% | 18.97% | 16.95% | -23.81% |
| Normalized Diluted EPS | 18.18% | 6.06% | 16.67% | 16.22% | -22.22% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |